午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook--->CAS DataBase List--->82773-21-5

82773-21-5

82773-21-5 Structure

82773-21-5 Structure
IdentificationBack Directory
[Name]

BroMocriptine IMpurity F
[CAS]

82773-21-5
[Synonyms]

BroMocriptine IMpurity F
Bromocriptine EP Impurity F
Bromocriptine Mesylate EP Impurity F)
Bromocriptine Impurity 6(Bromocriptine Mesylate EP Impurity F)
[Molecular Formula]

C32H40BrN5O5
[MOL File]

82773-21-5.mol
[Molecular Weight]

654.595
Chemical PropertiesBack Directory
[Boiling point ]

891.3±65.0 °C(Predicted)
[density ]

1.52±0.1 g/cm3(Predicted)
[pka]

9.60±0.60(Predicted)
[InChIKey]

OZVBMTJYIDMWIL-CCCBMRMVNA-N
[SMILES]

C1[C@@H](C(N[C@@]2(O[C@@]3(N([C@H](C(N4[C@@]3([H])CCC4)=O)CC(C)C)C2=O)O)C(C)C)=O)CN(C)[C@]2(C=1C1=C3C(C2)=C(Br)NC3=CC=C1)[H] |&1:1,4,6,8,11,31,r|
Hazard InformationBack Directory
[Description]

Bromocriptine impurity F (chemical name: (6aR,9R)-5-Bromo-N-[(2S,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide) is an impurity of Bromocriptine. Bromocriptine is in a class of medications called dopamine receptor agonists. It treats hyperprolactinemia by decreasing the amount of prolactin in the body. It treats acromegaly by decreasing the amount of growth hormone in the body. It treats Parkinson's disease by stimulating the nerves that control movement.
82773-21-5 suppliers list
Company Name: Moxin Chemicals
Tel: +8617320513646 , +8617320513646
Website: www.molcoo.com/
Company Name: China National Standard Pharmaceutical Corporation Limited
Tel: +8615391658522 , +8615391658522
Website: https://www.standardpharm.org.cn/
Company Name: ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel: +8618627948422 , +8618627948422
Website: www.hdimpurity.com/
Company Name: Guangzhou CATO Research Chemicals Inc.
Tel: +86-020-81960175-617 +8615602392859 , +8615602392859
Website: www.cato-chem.com/
Company Name: QUALITY CONTROL SOLUTIONS LTD.
Tel: 0755-66853366; 13670046396 , 13670046396
Website: https://www.qcsrm.com
Company Name: Hubei Moco Chemical Co., Ltd.  Gold
Tel: 18627753421 18627756402
Website: www.molcoo.com/
Company Name: Shanghai Kewel Chemical Co., Ltd.  
Tel: 021-64609169 18901607656
Website: http://www.kewelchem.com/
Company Name: Hubei Yangxin Medical Technology Co., Ltd.  
Tel: 15374522761
Website: http://www.standardpharm.com
Company Name: TOSUN PHARM  
Tel: 020-61855200 13326451905
Website: www.toref.cn/
Company Name: Jinan blalong chemical co. LTD  
Tel: 2710913286@.com
Website: www.yuhua99.com/showsupplierproductslist1068244/0.htm
Company Name: Hubei Xinyang Medical Technology Co., Ltd  
Tel: 15347293736 15347293736
Website: http://www.standardpharm.com
Company Name: Molcoo Chemicals Inc.  
Tel: 18576690171 17386083646
Website: http://www.molcoo.com/
Company Name: Cato Research Chemicals Inc.  
Tel: 020-81960175-877 18933936954
Website: www.cato-chem.com/
Company Name: Shanghai Haohong Scientific Co., Ltd.  
Tel: 400-400-8210725 17717813675;
Website: https://www.leyan.com/
Company Name: Shanghai Easy CDMO Co.,Ltd  
Tel: 021-61734564
Website:
Company Name: Shanghai Zerui Biotechnology Co., Ltd.  
Tel: 021-54580889 18321124657
Website: www.zr-pharmaceutical.com
Company Name: Henan Vcommend Consultrading Co., Ltd.  
Tel: 13393721940; 13393721940
Website: http://www.vcommend.com/
Company Name: ShenZhen H&D Pharmaceutical Technology Co., LTD  
Tel: 18672472998
Website: www.hdimpurity.com/
Tags:82773-21-5 Related Product Information
65700-36-9 511-09-1 20315-46-2 82796-58-5 25614-03-3 22260-51-1 478-83-1 2492-53-7

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept